A Phase I Dose-escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer
Halford, Sarah, Veal, Gareth J, Wedge, Stephen R, Payne, Geoffrey S, Bacon, Chris M, Sloan, Philip, Dragoni, Ilaria, Heinzmann, Kathrin, Potter, Sarah, Salisbury, Becky M, Chénard-Poirier, Maxime, Greystoke, Alastair, Howell, Elizabeth C, Innes, William A, Morris, Karen, Plummer, Chris, Rata, Mihaela, Petrides, George, Keun, Hector C, Banerji, Udai, Plummer, Ruth
Published in Clinical cancer research (14.04.2023)
Published in Clinical cancer research (14.04.2023)
Get full text
Journal Article